Prospective Registry and Biobank of Patients With Infectious Diseases

What this Trial Is About

Researchers are collecting information about patients with various infectious diseases to create a detailed database and biobank. This observational study focuses on illnesses such as bloodstream infections, central nervous system infections, bone and joint infections, endovascular infections, sexually transmitted infections, HIV infection, and emerging infectious diseases. The goal is to understand the clinical, laboratory, imaging, and microbiological features as well as treatment approaches, and to study factors affecting treatment success and disease outcomes. Participants will provide biological samples like blood, cerebrospinal fluid, and urine at the start of their infectious disease diagnosis. Data and samples will be collected at baseline, end of treatment, and six months later, or yearly for HIV patients. Additional collections may occur depending on disease progression or treatment changes. The study will record clinical scores, laboratory results, imaging, treatment details, drug levels, and outcomes including mortality and complications. Participants will be monitored through clinical and laboratory assessments at several time points including baseline, end of treatment, and follow-up visits. Researchers will use these data to analyze disease characteristics, treatment responses, and outcomes over time. The study aims to identify biomarkers, predictors of cure, and factors influencing mortality and complications. Participation involves donating samples and sharing medical information, with follow-up lasting at least six months or longer for some conditions.

INfectious DIsease REgistry BIObank